Pricing Log in Create free account
Friday 6 November 2026 Export AXSM’s income statement to Excel — free account

Axsome Therapeutics, Inc.

AXSM Healthcare Biotechnology

Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024.

Revenue
+51.9%
EPS
+73.9%
Free cash flow
−1,078.3%
Total debt
+4.04%

Quarter to September 2026, against a year earlier

132.13 2.33 +1.80%
Market cap
$6.8B
P/E
0.0×
Fwd P/E
−49.2×
Dividend yield
—
F-score
5/9
Altman Z
6.91
Beneish M
−2.53
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Axsome Therapeutics, Inc. (AXSM) Book value per share

Alert me on Book value per share

Axsome Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 1.8×, up 49.2% from 1.2× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.0×. Over the past ten years it has ranged from 0.0× (fiscal 2018) to 5.3× (fiscal 2019); the current reading is higher than 55% of that period. Axsome Therapeutics, Inc. ranks 277th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 1.8× 49.16%
FY2024 1.2× (71.70%)
FY2023 4.2× 56.02%
FY2022 2.7× 548.54%
FY2021 0.4× (86.41%)
FY2020 3.1× (41.78%)
FY2019 5.3× 14,953.01%
FY2018 0.0× (95.25%)
FY2017 0.7× (34.80%)
FY2016 1.1× (71.03%)

Quarterly newest first

Period Book value per share Change
Sep 2026 2.0× 25.01%
Jun 2026 1.6× 50.83%
Mar 2026 1.1× (39.93%)
Dec 2025 1.8× 20.42%
43 more quarters

Against its own ten years

Low 0.0× High 5.3×
Ten-year median 1.8×
Current reading's percentile 55

Book value per share against peers

Company Book value per share
LGND Ligand Pharmaceuticals Incorporated compare 48.2×
PRAX Praxis Precision Medicines, Inc. compare 46.0×
BLTE Belite Bio, Inc. Sponsored ADR compare 19.3×
ORKA Oruka Therapeutics, Inc. compare 17.7×
ABVX Abivax SA Sponsored ADR compare 5.3×
RYTM Rhythm Pharmaceuticals, Inc. compare 2.9×
IONS Ionis Pharmaceuticals, Inc. compare 2.7×
AXSM Axsome Therapeutics, Inc. 2.0×
MIRM Mirum Pharmaceuticals, Inc. compare −0.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on AXSM